THE DUAL PPAR ALPHA/GAMMA AGONIST ALEGLITAZAR HAS A BENEFICIAL EFFECT ON ATHEROGENIC DYSLIPIDEMIA IN

来源 :第二十四届长城国际心脏病学会议、亚太心脏大会暨国际心血管病预防与康复会议(The 24th Great Wall Int | 被引量 : 0次 | 上传用户：dotnetgroup

【摘要】

：

【作者】

：

Matthias Herz Klas Malmberg Markolf Hanefeld A Michael Lincoff Nadejda Mudie Stephen Nicholls

【机构】

：

F.Hoffmann-La Roche Center for Clinical Studies,T

【出处】

：

第二十四届长城国际心脏病学会议、亚太心脏大会暨国际心血管病预防与康复会议(The 24th Great Wall Int

【发表日期】

：

2013年2期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Objectives Dyslipidemia, characterised by increased ratios of triglycerides (TG) and total cholesterol (TC) to high-density lipoprotein cholesterol (HDL-C), is a cardiovascular (CV) risk factor in patients with type 2 diabetes (T2D).1 In addition to evaluating renal effects of aleglitazar in stage 3 chronic kidney disease patients with T2D, this Phase Ⅱb study (AleNephro) assessed effects on CV risk factors, including lipid ratios.

其他文献

CLINICAL ANALYSIS OF 19 PATIENTS WITH ARRHYTHMIAS CAUSED BY ACUTE ACONITINE POISONING

Objectives To explore clinical characteristics and emergency treatment of patients with arrhythmias caused by acute aconitine poisoning.Methods We conducted a retrospective analysis during the period

会议

EFFICACY AND SAFETY OF ATORVASTATIN IN THE TREATMENT BETWEEN YOUNG-ELDERLY AND OLD-ELDERLY PATIENTS

Objectives To gain insight into the difference of efficacy and safety of atorvastatin between young-elderly and old-elderly patients with dyslipidemia.Methods 88 dyslipidemia elderly patients with hig

会议

SAFETY OF CLOPIDOGREL AND PROTON PUMP INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERV

Objectives To perform a meta-analysis in order to determine safety of concomitant use of clopidogrel and proton pump inhibitors (PPIs) in patients undergoing percutaneous coronary intervention (PCI).M

会议

THE CLINICAL RESEARCH FOR SAFETY AND AVAILABILITY OF LOW-INTENSITY ANTICOAGULATION WITH WARFARIN THE

Objectives To observe the safety and availability of anticoagulation of low-intensity warfarin anticoagulant therapy in AF patients with high stroke risk and high risk of bleeding applying CHA2DS2VASc

会议

XUEZHIKANG CAN REDUCE ARTERIAL STIFFNESS IN PATIENTS WITH ESSENTIAL HYPERTENSION,INDEPENDENT OF LIPI

Objectives Increased arterial stiffness occurs early in hypertension and is considered to play an important role in cardiovascular events.Xuezhikang, an extract of Cholestin, contains statinlike compo

会议

META-ANALYSIS: EFFECTS OF STATINS ON RENAL FUNCTION

Objectives Statins can significantly improve the lipid profile and reduce cardiovascular events.But safety of statins on renal function is still controversial.Methods Pubmed, the Cochrane Central Regi

会议

POSTMARKETING SURVEILLANCE STUDY WITH IODIXANOL IN 20185 CHINESE PATIENTS FROM ROUTINE CLINICAL PRAC

Objectives To determine prospectively the incidence and nature of immediate and delayed ADRs occurring after administration of iodixanol in routine clinical practices among non-selected patients, and

会议

SAFETY AND EFFECTIVENESS OF VERAPAMIL PREVENTING NO-REFLOW: A SYSTEMATIC REVIEW

Objectives To evaluate the clinical efficacy and safety of verapamil injection for preventing slow-flow/no-reflow phenomenon after percutaneous coronary intervention.Methods We searched the Cochrane C

会议

ROSUVASTATIN PREVENTS CONTRAST-INDUCED NEPHROPATHY IN DIABETIC NEPHROPATHY RATS

Objectives The aim of the present study was to assess the effects of rosuvastatin on contrast-induced nephropathy (CIN) in diabetic nephropathy rats.Methods Male SD rats, using a single intraperitonea

会议

THE OBSERVATION OF THE FLEABANE INJECTION CLINICAL CURATIVE EFFECT ON THE OLD PATIENTS WITH ACUTE CO

Objectives To observe the fleabane injection clinical curative effect and security on the patients with acute coronary syndrome.Methods We divided 66 patients with acute coronary syndrome into 2 group

会议

THE DUAL PPAR ALPHA/GAMMA AGONIST ALEGLITAZAR HAS A BENEFICIAL EFFECT ON ATHEROGENIC DYSLIPIDEMIA IN

与本文相关的学术论文